Synta Pharmaceuticals
45 Hartwell Avenue
Lexington
Massachusetts
02421
United States
Tel: 781-274-8200
Fax: 781-274-8228
Website: http://www.syntapharma.com/
Email: info@syntapharma.com
321 articles about Synta Pharmaceuticals
-
Movers and Shakers Oct. 1
10/1/2018
Here's a look at who shook things up in the world of pharma and biotech this week. -
Synta Announces Date And Location Of Annual Meeting Of Stockholders To Vote On Merger With Madrigal
6/9/2016
-
Synta To Present At Upcoming Investor Conferences In June
6/2/2016
-
After Exploring Strategic Alternatives, Synta Agrees to Merge with Madrigal to Create Leading Cardio-Metabolic Diseases and NASH Company
4/14/2016
-
Stock Plunges as Synta Terminates Phase III Lung Cancer Study
10/22/2015
-
Syntethic Biologics, Inc.' s Novel Irritable Bowel Syndrome With Constipation (IBS-C) Program Featured In Synta Poster
10/21/2015
-
Synta Announces Formation Of Expert Oncology Panel
10/8/2015
-
Synta Names Alan C. Rigby, Ph.D. Chief Scientific Officer
9/9/2015
-
Synta Announces Presentations At The 16th Annual World Conference On Lung Cancer
9/8/2015
-
Synta To Participate In FBR Second Annual Healthcare Conference
9/3/2015
-
Synta Reports Second Quarter 2015 Financial Results
8/6/2015
-
Synta To Host Conference Call And Webcast Of Second Quarter 2015 Financial Results On August 6, 2015
7/31/2015
-
Synta Announces Journal Publication Describing Complementary Activity Of Hsp90 Inhibition And Immune Checkpoint Blockade For Cancer Therapy
6/23/2015
-
Synta To Participate In Upcoming Investor Conferences
6/17/2015
-
Synta Announces Ganetespib Program Updates
6/2/2015
-
ASCO15: Synta Announces Presentations At The 2015 ASCO Annual Meeting
5/29/2015
-
Synta To Present At The Jefferies and Co. 2015 Global Healthcare Conference
5/28/2015
-
Synta Reports First Quarter 2015 Financial Results
5/7/2015
-
Synta To Host Conference Call And Webcast Of First Quarter 2015 Financial Results On May 7, 2015
5/1/2015
-
Synta CEO Steps Down, Replacement Named
4/27/2015